Talk:Forasartan

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Forasartan.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Moved from article[edit]

I have moved the following content here because it lacks context/explanation. If anyone wants to use it to improve the article, here it is. -- Ed (Edgar181) 18:42, 12 July 2016 (UTC)[reply]

[[File:Forasartan synthesis.png|thumb|center|700px|Forasartan synthesis:<ref>{{Cite journal | doi = 10.1016/S0960-894X(01)81126-4| title = A new class of balanced AT1/AT2 angiotensin II antagonists: Quinazolinone AII antagonists with acylsulfonamide and sulfonylcarbamate acidic functionalities| journal = Bioorganic & Medicinal Chemistry Letters| volume = 4| pages = 81| year = 1994| last1 = Glinka | first1 = T. W. | last2 = De Laszlo | first2 = S. E. | last3 = Siegl | first3 = P. K. S. | last4 = Chang | first4 = R. S. | last5 = Kivlighn | first5 = S. D. | last6 = Schorn | first6 = T. S. | last7 = Faust | first7 = K. A. | last8 = Chen | first8 = T. B. | last9 = Zingaro | first9 = G. J. | last10 = Lotti | first10 = V. J. | last11 = Greenlee | first11 = W. J. }}</ref>]] N.B. Same journal issue contains many similar analogs.